{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:07:52Z","timestamp":1793833672839,"version":"4.6.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031256","name":"Symbiosis International University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mimet.2026.107544","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:24:59Z","timestamp":1778423099000},"page":"107544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multidrug-resistant Acinetobacter baumannii: Molecular insights, clinical challenges, and therapeutic approaches"],"prefix":"10.1016","volume":"246","author":[{"given":"Komal","family":"Ghonse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Koratkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mimet.2026.107544_bb0005","article-title":"Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: an innovative approach","author":"Abolfazl Jahangiri","year":"2018","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.mimet.2026.107544_bib403","doi-asserted-by":"crossref","first-page":"106184","DOI":"10.1016\/j.micpath.2023.106184","article-title":"Anti-capsular activity of CuO nanoparticles against Acinetobacter baumannii produce efflux pump","volume":"181","author":"Al-Kadmy","year":"2023","journal-title":"Microbial Pathogenesis"},{"issue":"6","key":"10.1016\/j.mimet.2026.107544_bb0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s13346-023-01513-6","article-title":"Antibiotic resistance and tolerance: what can drug delivery do against this global threat?","volume":"14","author":"Aparicio-Blanco","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.mimet.2026.107544_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109828","article-title":"Targeting the quorum sensing network in Acinetobacter baumannii: a dual target structure-based approach for the development of novel antimicrobials","author":"Bell","year":"2025","journal-title":"Comput. Biol. Med."},{"issue":"34","key":"10.1016\/j.mimet.2026.107544_bb0020","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1073\/pnas.1523116113","article-title":"Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis","volume":"113","author":"Bhuiyan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mimet.2026.107544_bb0025","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/cid\/ciad109","article-title":"Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus complex","volume":"76","author":"Castanheira","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mimet.2026.107544_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3754018","article-title":"Biomedical potentialities of silver nanoparticles for clinical multiple drug-resistant Acinetobacter baumannii","volume":"2019","author":"Chen","year":"2019","journal-title":"J. Nanomater."},{"issue":"2","key":"10.1016\/j.mimet.2026.107544_bb0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3904\/kjim.2015.178","article-title":"Controlling endemic multidrug-resistant Acinetobacter baumannii in intensive care units using antimicrobial stewardship and infection control","volume":"31","author":"Cheon","year":"2016","journal-title":"Korean J. Intern. Med."},{"issue":"5","key":"10.1016\/j.mimet.2026.107544_bb0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41564-018-0151-5","article-title":"A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii","volume":"3","author":"Chin","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"11","key":"10.1016\/j.mimet.2026.107544_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111800","article-title":"Development of novel peptides for the antimicrobial combination therapy against carbapenem-resistant Acinetobacter baumannii infection","volume":"13","author":"Choi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.mimet.2026.107544_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drup.2012.07.001","article-title":"Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?","volume":"15","author":"Dai","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.mimet.2026.107544_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/jcpt.13787","article-title":"Acinetobacter baumannii: pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline","author":"Dehbanipour","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.mimet.2026.107544_bib412","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.2147\/IDR.S468413","article-title":"Carrimycin, as one of the drugs in combination therapy, for the treatment of Carbapenem-Resistant Acinetobacter baumannii infection","author":"Du","year":"2024","journal-title":"Infection and Drug Resistance"},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00279-24","article-title":"Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen","volume":"38","author":"Dubey","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41426-018-0030-4","article-title":"Acinetobacter: an emerging pathogen with a versatile secretome review-article","volume":"7","author":"Elhosseiny","year":"2018","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-025-01837-1","article-title":"Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii","volume":"15","author":"Elshamy","year":"2025","journal-title":"AMB Express"},{"key":"10.1016\/j.mimet.2026.107544_bb0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.26502\/ami.936500213","article-title":"Antibacterial activity and antibiofilm of essential oils of clove and thyme against clinical isolates of multidrug-resistant Acinetobacter baumannii associated with nosocomial infections","author":"Ezzariga","year":"2025","journal-title":"Arch. Microbiol. Immunol."},{"issue":"8","key":"10.1016\/j.mimet.2026.107544_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00297-18","article-title":"Identification of novel Acinetobacter baumannii type VI secretion system antibacterial effector and immunity pairs","volume":"86","author":"Fitzsimons","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mimet.2026.107544_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1556656","article-title":"The fitness connection of antibiotic resistance","volume":"16","author":"Fuzi","year":"2025","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.mimet.2026.107544_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12111590","article-title":"Evaluation of antibiotic resistance mechanisms in gram-negative bacteria","volume":"12","author":"Gauba","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.mimet.2026.107544_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcsw.2023.100112","article-title":"Alternative mechanisms of action of metallic nanoparticles to mitigate the global spread of antibiotic-resistant bacteria","volume":"10","author":"Girma","year":"2023","journal-title":"Cell Surf."},{"issue":"11","key":"10.1016\/j.mimet.2026.107544_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13111064","article-title":"Comprehensive approaches to combatting Acinetobacter baumannii biofilms: from biofilm structure to phage-based therapies","volume":"13","author":"Grygiel","year":"2024","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/j.mimet.2026.107544_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00203-022-03020-7","article-title":"PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid medium","volume":"204","author":"Grygorcewicz","year":"2022","journal-title":"Arch. Microbiol."},{"issue":"4","key":"10.1016\/j.mimet.2026.107544_bib408","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry","volume":"11","author":"Gu Liu","year":"2020","journal-title":"MBio"},{"issue":"10","key":"10.1016\/j.mimet.2026.107544_bb0115","doi-asserted-by":"crossref","DOI":"10.1099\/mgen.0.000306","article-title":"Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii","volume":"5","author":"Hamidian","year":"2019","journal-title":"Microb. Genomics"},{"issue":"22","key":"10.1016\/j.mimet.2026.107544_bb0120","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1074\/jbc.M117.781575","article-title":"Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems","volume":"292","author":"Harding","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mimet.2026.107544_bib410","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/jac\/dkad042","article-title":"Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients","volume":"78","author":"Heil","year":"2023","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s44259-025-00087-2","article-title":"Emerging antimicrobial therapies for gram-negative infections in human clinical use","volume":"3","author":"Hickson","year":"2025","journal-title":"Npj Antimicrob. Resist."},{"issue":"JAN","key":"10.1016\/j.mimet.2026.107544_bb0130","article-title":"Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice","volume":"8","author":"Hua","year":"2018","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.mimet.2026.107544_bib413","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/medicina60071086","article-title":"Genomic insights into and in vitro evaluation of antimicrobial combination therapies for carbapenem-resistant Acinetobacter baumannii","volume":"60","author":"Ijaz","year":"2024","journal-title":"Medicina"},{"issue":"12","key":"10.1016\/j.mimet.2026.107544_bib401","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/pathogens13121049","article-title":"Colistin resistance mechanism and management strategies of colistin-resistant Acinetobacter baumannii infections","volume":"13","author":"Islam","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bib409","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01110-18","article-title":"New treatment options against carbapenem-resistant Acinetobacter baumannii infections","volume":"63","author":"Isler","year":"2019","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/acsinfecdis.7b00168","article-title":"Acinetobacter baumannii OmpA is a selective antibiotic permeant porin","volume":"4","author":"Iyer","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"12","key":"10.1016\/j.mimet.2026.107544_bib407","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/antibiotics12121729","article-title":"Cefiderocol and sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii","volume":"12","author":"Karruli","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"22","key":"10.1016\/j.mimet.2026.107544_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212520","article-title":"Antiseptic 9-meric peptide with potency against carbapenem-resistant Acinetobacter baumannii infection","volume":"22","author":"Krishnan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.mimet.2026.107544_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01063-24","article-title":"Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations","volume":"69","author":"Kubin","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.mimet.2026.107544_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9102104","article-title":"Virulence potential and treatment options of multidrug-resistant (Mdr) Acinetobacter baumannii","volume":"9","author":"Kumar","year":"2021","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.mimet.2026.107544_bib399","series-title":"Open forum infectious diseases","article-title":"April). Phage therapy for a multidrug-resistant Acinetobacter baumannii craniectomy site infection","volume":"(Vol. 5, No. 4,","author":"LaVergne","year":"2018"},{"issue":"MAR","key":"10.1016\/j.mimet.2026.107544_bb0170","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.mimet.2026.107544_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftz004","article-title":"Tug of war between Acinetobacter baumannii and host immune responses","volume":"76","author":"Li","year":"2018","journal-title":"Pathog. Dis."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-024-03489-w","article-title":"Biological and genomic characterization of a polyvalent phage PSH-1 against multidrug-resistant Salmonella Enteritidis","volume":"24","author":"Li","year":"2024","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s44259-024-00046-3","article-title":"Mechanisms of antimicrobial resistance in biofilms","volume":"2","author":"Liu","year":"2024","journal-title":"Npj Antimicrob. Resist."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0190","article-title":"Discovery, structural characteristics and evolutionary analyses of functional domains in Acinetobacter baumannii phage tail fiber\/spike proteins","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.mimet.2026.107544_bb0195","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.43656","article-title":"Molecular characterization of class A-ESBLs, class B-MBLs, class C-AmpC, and class D-OXA carbapenemases in MDR Acinetobacter baumannii clinical isolates in a tertiary care hospital, West Bengal, India","author":"Longjam","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.mimet.2026.107544_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxbio.2025.100003","article-title":"Emerging technologies and innovative approaches to combat antimicrobial resistance: a narrative review of next-generation therapeutic strategies","volume":"1","author":"Lucero-Prisno","year":"2025","journal-title":"Next Bioeng."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00332-24","article-title":"The BfmRS stress response protects Acinetobacter baumannii against defects in outer membrane lipoprotein biogenesis","volume":"207","author":"Marotta","year":"2025","journal-title":"J. Bacteriol."},{"issue":"2","key":"10.1016\/j.mimet.2026.107544_bib404","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/acsomega.3c06114","article-title":"Radical scavenging, hemocompatibility, and antibacterial activity against MDR Acinetobacter baumannii in alginate-based aerogels containing lipoic acid-capped silver nanoparticles","volume":"9","author":"Martinez-Garcia","year":"2024","journal-title":"ACS omega"},{"key":"10.1016\/j.mimet.2026.107544_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810893","article-title":"Plasmids as key players in Acinetobacter adaptation","author":"Maslova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.mimet.2026.107544_bb0215","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","article-title":"CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance","volume":"9","author":"Mayorga-Ramos","year":"2023","journal-title":"ACS Infect. Dis."},{"issue":"7","key":"10.1016\/j.mimet.2026.107544_bb0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/fmb-2023-0248","article-title":"Sulbactam\u2013durlobactam: a \u03b2-lactam\/\u03b2-lactamase inhibitor combination targeting Acinetobacter baumannii","volume":"19","author":"McLeod","year":"2024","journal-title":"Future Microbiol."},{"issue":"12","key":"10.1016\/j.mimet.2026.107544_bb0225","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10096-023-04677-8","article-title":"Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies","volume":"42","author":"Mendes","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"15","key":"10.1016\/j.mimet.2026.107544_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155498","article-title":"Mechanisms protecting Acinetobacter baumannii against multiple stresses triggered by the host immune response, antibiotics, and outside host environment","volume":"21","author":"Monem","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"JULY","key":"10.1016\/j.mimet.2026.107544_bb0235","article-title":"The mechanisms of disease caused by Acinetobacter baumannii","volume":"10","author":"Morris","year":"2019","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0240","article-title":"Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Moubareck","year":"2020","journal-title":"Antibiotics"},{"issue":"10325","key":"10.1016\/j.mimet.2026.107544_bb0245","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhin.2019.09.021","article-title":"Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii","volume":"104","author":"Nasr","year":"2020","journal-title":"J. Hosp. Infect."},{"issue":"9","key":"10.1016\/j.mimet.2026.107544_bib405","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/antibiotics12091365","article-title":"Inhibition of Acinetobacter baumannii biofilm formation using different treatments of silica nanoparticles","volume":"12","author":"Natsheh","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.mimet.2026.107544_bb0255","doi-asserted-by":"crossref","DOI":"10.37349\/eds.2025.1008133","article-title":"Synergism of phages and antimicrobial peptides for treating multidrug resistant bacterial pathogens","volume":"3","author":"Nayab","year":"2025","journal-title":"Explor. Drug Sci."},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12030516","article-title":"Colistin resistance in Acinetobacter baumannii: molecular mechanisms and epidemiology","volume":"12","author":"Novovi\u0107","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.mimet.2026.107544_bb0265","article-title":"Engineered nanoparticles for combating drug-resistant bacteria and bacterial biofilms","author":"Pechnikova","year":"2025","journal-title":"ACS Nano Med."},{"issue":"6","key":"10.1016\/j.mimet.2026.107544_bb0270","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/21505594.2016.1262313","article-title":"The FhaB\/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12o-A2 strain","volume":"8","author":"P\u00e9rez","year":"2017","journal-title":"Virulence"},{"issue":"7","key":"10.1016\/j.mimet.2026.107544_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071353","article-title":"Gram-negative bacteria holding together in a biofilm: the Acinetobacter baumannii way","volume":"9","author":"Pompilio","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/mmi.13872","article-title":"Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin","volume":"107","author":"Powers","year":"2018","journal-title":"Mol. Microbiol."},{"issue":"11","key":"10.1016\/j.mimet.2026.107544_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31728","article-title":"Use of nanotechnology-based nanomaterial as a substitute for antibiotics in monogastric animals","volume":"10","author":"Qadeer","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.mimet.2026.107544_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.952491","article-title":"Deciphering the genetic network and programmed regulation of antimicrobial resistance in bacterial pathogens","volume":"12","author":"Ramamurthy","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-10081-0","article-title":"Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii","volume":"24","author":"Rastegar","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-025-04323-4","article-title":"Innovative approaches to combat antibiotic resistance: integrating CRISPR\/Cas9 and nanoparticles against biofilm-driven infections","volume":"23","author":"Saffari Natanzi","year":"2025","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.mimet.2026.107544_bb0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11274-024-03977-1","article-title":"Co-production of metallo-\u03b2-lactamase and OXA-type \u03b2-lactamases in carbapenem-resistant Acinetobacter baumannii clinical isolates in North East India","volume":"40","author":"Saikia","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"10","key":"10.1016\/j.mimet.2026.107544_bib397","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bib406","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/antibiotics10010057","article-title":"Enhanced antimicrobial and antibiofilm effect of new colistin-loaded human albumin nanoparticles","volume":"10","author":"Scutera","year":"2021","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.mimet.2026.107544_bib414","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/antibiotics13060506","article-title":"Antibiotic treatment of carbapenem-resistant Acinetobacter baumannii infections in view of the newly developed \u03b2-lactams: a narrative review of the existing evidence","volume":"13","author":"Serapide","year":"2024","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.mimet.2026.107544_bb0310","doi-asserted-by":"crossref","DOI":"10.3171\/2019.5.FOCUS19278","article-title":"Outcome following postneurosurgical Acinetobacter meningitis: an institutional experience of 72 cases","volume":"47","author":"Sharma","year":"2019","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.mimet.2026.107544_bb0315","article-title":"Acinetobacter baumannii: an evolving and cunning opponent","volume":"15","author":"Shi","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mimet.2026.107544_bb0320","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/ciad094","article-title":"Navigating available treatment options for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex infections","volume":"76","author":"Shields","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.mimet.2026.107544_bib400","doi-asserted-by":"crossref","first-page":"51","DOI":"10.34172\/ajcmi.2021.10","article-title":"Effect of Zinc Oxide Nanoparticles on Loaded Antibiotics Against Multidrug-Resistant Acinetobacter spp","volume":"8","author":"Shokrollahi","year":"2021","journal-title":"Avicenna Journal of Clinical Microbiology and Infection"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0325","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-024-03654-1","article-title":"Regulation of antibiotic persistence and pathogenesis in Acinetobacter baumannii by glutamate and histidine metabolic pathways","volume":"25","author":"Sim","year":"2025","journal-title":"BMC Microbiol."},{"issue":"8","key":"10.1016\/j.mimet.2026.107544_bb0330","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001867","article-title":"Deciphering the impact of Acinetobacter baumannii on human health, and exploration of natural compounds as efflux pump inhibitors to treat multidrug resistance","volume":"73","author":"Sivarajan","year":"2024","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11030412","article-title":"Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents","volume":"11","author":"Skwarczynski","year":"2022","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bib402","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5937\/scriptamed55-49892","article-title":"Inhibitory effect of selenium nanoparticles on the biofilm formation of multidrug-resistant Acinetobacter baumannii","volume":"55","author":"\u0160mitran","year":"2024","journal-title":"Scripta Medica"},{"key":"10.1016\/j.mimet.2026.107544_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.631585","article-title":"Clinical experience of personalized phage therapy against carbapenem-resistant Acinetobacter baumannii lung infection in a patient with chronic obstructive pulmonary disease","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.mimet.2026.107544_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/biology12030358","article-title":"Genomic comparative analysis of two multi-drug resistance (MDR) Acinetobacter baumannii clinical strains assigned to international clonal lineage II recovered pre- and post-COVID-19 pandemic","volume":"12","author":"Traglia","year":"2023","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s40104-021-00570-6","article-title":"Bacteriophage cocktail supplementation improves growth performance, gut microbiome and production traits in broiler chickens","volume":"12","author":"Upadhaya","year":"2021","journal-title":"J. Anim. Sci. Biotechnol."},{"issue":"10","key":"10.1016\/j.mimet.2026.107544_bb0355","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/antibiotics11101379","article-title":"Fitness costs of tigecycline resistance in Acinetobacter baumannii and the resistance mechanism revealed by a transposon mutation library","volume":"11","author":"Wang","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.mimet.2026.107544_bb0360","series-title":"A Novel Genus of Virulent Phage Targeting Acinetobacter baumannii. Efficacy and Safety in a Murine Model of Pulmonary Infection","author":"Wang","year":"2024"},{"key":"10.1016\/j.mimet.2026.107544_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128105","article-title":"Simultaneous functional disruption of the iron acquisition system and type VI secretion system results in complete suppression of virulence in Acinetobacter baumannii","volume":"295","author":"Wang","year":"2025","journal-title":"Microbiol. Res."},{"issue":"11","key":"10.1016\/j.mimet.2026.107544_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics14111134","article-title":"Phage therapy for Acinetobacter baumannii infections: a review on advances in classification, applications, and translational roadblocks","volume":"14","author":"Wang","year":"2025","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bib396","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","article-title":"Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients","volume":"10","author":"Wu","year":"2021","journal-title":"Emerging microbes & infections"},{"issue":"1","key":"10.1016\/j.mimet.2026.107544_bb0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3934\/bioeng.2025002","article-title":"Novel antimicrobial strategies against infections","volume":"12","author":"Xu","year":"2025","journal-title":"AIMS Bioeng."},{"key":"10.1016\/j.mimet.2026.107544_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00286","article-title":"Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances","volume":"8","author":"Yeh","year":"2020","journal-title":"Front. Chem."},{"issue":"10","key":"10.1016\/j.mimet.2026.107544_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11101406","article-title":"Recent progress in phage therapy to modulate multidrug-resistant Acinetobacter baumannii, including in human and poultry","volume":"11","author":"Zhang","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.mimet.2026.107544_bb0390","article-title":"Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mimet.2026.107544_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128232","article-title":"Advancements in CRISPR-Cas-based strategies for combating antimicrobial resistance","author":"Zhang","year":"2025","journal-title":"Microbiol. Res."}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701226001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701226001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:41:58Z","timestamp":1784202118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701226001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":94,"alternative-id":["S0167701226001569"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2026.107544","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug-resistant Acinetobacter baumannii: Molecular insights, clinical challenges, and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2026.107544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107544"}}